Spatiotemporal control of
singlet oxygen ((1)O2) release is a major challenge for
photodynamic therapy (
PDT) against
cancer with high therapeutic efficacy and minimum side effects. Here a
selenium-
rubyrin (NMe2Se4N2)-loaded nanoparticle functionalized with
folate (FA) was designed and synthesized as an acidic pH-activatable targeted
photosensitizer. The nanoparticles could specifically recognize
cancer cells via the FA-FA receptor binding and were selectively taken up by
cancer cells via receptor-mediated endocytosis to enter lysosomes, in which NMe2Se4N2 was activated to produce (1)O2. The pH-controllable release of (1)O2 specially damaged the lysosomes and thus killed
cancer cells in a lysosome-associated pathway. The introduction of
selenium into the
rubyrin core enhanced the (1)O2 generation efficiency due to the heavy atom effect, and the substitution of dimethylaminophenyl moiety at meso-position led to the pH-controllable activation of NMe2Se4N2. Under near-infrared (NIR) irradiation, NMe2Se4N2 possessed high
singlet oxygen quantum yield (ΦΔ) at an acidic pH (ΦΔ = 0.69 at pH 5.0 at 635 nm) and could be deactivated at physiological pH (ΦΔ = 0.06 at pH 7.4 at 635 nm). The subcellular location-confined pH-activatable
photosensitization at NIR region and the
cancer cell-targeting feature led to excellent capability to selectively kill
cancer cells and prevent the damage to normal cells, which greatly lowered the side effects. Through
intravenous injection of FA-NMe2Se4N2 nanoparticles in
tumor-bearing mice,
tumor elimination was observed after NIR irradiation. This work presents a new paradigm for specific
PDT against
cancer and provides a new avenue for preparation of highly efficient
photosensitizers.